DUBLIN--(BUSINESS WIRE)--May 4, 2021--

This report delivers an in-depth understanding of the migraine, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

The Migraine market report provides current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted migraine symptoms market size from 2018 to 2030 segmented by seven major markets. The report also covers current Migraine symptoms treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.

Key Findings

This section includes a glimpse of the Migraine market in 7MM. The market size of migraine in the seven major markets was USD 5,592 million in 2020, and the market is estimated to increase for the study period (2018-2030).

The United States Market Outlook

This section provides a total of Migraine market size and market size by therapies in the United States.

The United States accounts for the largest MIGRAINE market size than the EU5 (the United Kingdom, Germany, Italy, France, and Spain) and Japan.

EU-5 Countries: Market Outlook

The total Migraine market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom are provided in this section.

Scope of the Report

  • The report covers the descriptive overview of migraine, explaining its causes, signs and symptoms, pathophysiology, and currently available therapies
  • Comprehensive insight has been provided into the Migraine epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for migraine is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of the Migraine market; historical and forecasted, is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies by understanding trends shaping and driving the global Migraine market

Report Highlights

  • In the coming years, the Migraine market is set to change due to the rising awareness of the disease and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
  • The companies and academics are working to assess challenges and seek opportunities that could influence Migraine R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
  • Major players are involved in developing therapies for MIGRAINE. The launch of emerging therapies will significantly impact the Migraine market
  • A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for migraine
  • Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends, and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Reasons to Buy

  • The report will help in developing business strategies by understanding trends shaping and driving the Migrainemarket
  • To understand the future market competition in the Migraine market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Migraine in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Migraine market
  • To understand the future market competition in the Migraine market

Companies Mentioned

  • AbbVie
  • Allergan
  • Amgen/Novartis
  • Axsome Therapeutics
  • Biohaven Pharmaceuticals
  • Dr. Reddy's Labs
  • Eli Lilly and Company
  • Impel NeuroPharma
  • Lundbeck Seattle BioPharmaceutical
  • Teva Pharmaceuticals
  • Zosano Pharma

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/8g9a1r

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 05/04/2021 12:05 PM/DISC: 05/04/2021 12:05 PM

Recommended For You


Copyright Business Wire 2021.